| 3D-QSAR, molecular dynamics simulations and molecular docking studies of benzoxazepine moiety as mTOR inhibitor for the treatment of lung cancer U Chaube, D Chhatbar, H Bhatt Bioorganic & medicinal chemistry letters 26 (3), 864-874, 2016 | 49 | 2016 |
| CoMFA, CoMSIA, Topomer CoMFA, HQSAR, molecular docking and molecular dynamics simulations study of triazine morpholino derivatives as mTOR inhibitors for the treatment of … DM Chhatbar, UJ Chaube, VK Vyas, HG Bhatt Computational Biology and Chemistry 80, 351-363, 2019 | 38 | 2019 |
| 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors U Chaube, H Bhatt Molecular Diversity 21, 741-759, 2017 | 20 | 2017 |
| Design and development of Tetrahydro-Quinoline derivatives as dual mTOR-C1/C2 inhibitors for the treatment of lung cancer UJ Chaube, R Rawal, AB Jha, B Variya, HG Bhatt Bioorganic Chemistry 106, 104501, 2021 | 18 | 2021 |
| Beneficial effect of silymarin in pressure overload induced experimental cardiac hypertrophy B Sharma, U Chaube, BM Patel Cardiovascular Toxicology 19, 23-35, 2019 | 18 | 2019 |
| Tetrahydroquinoline: an efficient scaffold as mTOR inhibitor for the treatment of lung cancer U Chaube, R Dey, S Shaw, BD Patel, HG Bhatt Future Medicinal Chemistry 14 (23), 1789-1809, 2022 | 11 | 2022 |
| ChemistrySelect S Shaw, R Dey, H Bhatt, B Patel, S Patel, N Dixit, U Chaube | 10 | 2019 |
| Design and synthesis of potent N-phenylpyrimidine derivatives for the treatment of skin cancer UJ Chaube, VK Vyas, HG Bhatt RSC advances 6 (13), 10285-10297, 2016 | 10 | 2016 |
| A hypothesis on designing strategy of effective RdRp inhibitors for the treatment of SARS-CoV-2 U Chaube, BD Patel, HG Bhatt 3 Biotech 13 (1), 12, 2023 | 6 | 2023 |
| Discovery of novel CaMK-II inhibitor for the possible mitigation of arrhythmia through pharmacophore modelling, virtual screening, molecular docking, and toxicity prediction N Parekh, S Lakhani, A Patel, D Oza, B Patel, R Yadav, U Chaube Artificial Intelligence Chemistry 1 (2), 100009, 2023 | 3 | 2023 |
| Ellagic acid improves the symptoms of early-onset Alzheimer's disease: Behavioral and physiological correlates AB Jha, UJ Chaube, AB Jha Heliyon 10 (18), 2024 | 2 | 2024 |
| Designing of target‐specific N‐substituted tetrahydroquinoline derivatives as potent mTOR inhibitors via integrated structure‐guided computational approaches S Shaw, R Dey, H Bhatt, B Patel, S Patel, N Dixit, U Chaube ChemistrySelect 9 (7), e202303291, 2024 | 2 | 2024 |
| Identification of potent, non-toxic, selective CDK2 inhibitor through the pharmacophore-based scaffold hopping, molecular dynamics simulation-assisted molecular docking study … U Chaube, H Bhatt Structural Chemistry 33 (6), 1895-1905, 2022 | 2 | 2022 |
| Advancements in mTOR Inhibitors for Non-Small Cell Lung Cancer: Mechanisms, Efficacy, and Future Perspectives A Thaker, S Patel, R Dey, S Shaw, B Patel, H Bhatt, UJ CHAUBE Synlett, 2024 | 1 | 2024 |
| Synthesis, biological screening, and binding mode analysis of some N-substituted tetrahydroquinoline analogs as apoptosis inducers and anticancer agents R Dey, S Shaw, H Bhatt, B Patel, R Yadav, U Chaube Journal of Molecular Structure 1318, 139330, 2024 | 1 | 2024 |
| Small Molecule Drug Design R Dey, U Chaube, H Bhatt, B Patel Elsevier, 2024 | 1 | 2024 |
| Homology modeling, binding site identification, molecular docking and molecular dynamics simulation study of emerging and promising drug target of Wnt signaling–Human Porcupine … V Goswami, D Patel, S Rohit, U Chaube, B Patel Results in Chemistry 7, 101482, 2024 | 1 | 2024 |
| Morpholine-Substituted Tetrahydroquinoline Derivatives as Potential mTOR Inhibitors: Synthesis, Computational Insights, and Cellular Analysis R Dey, S Shaw, R Yadav, BD Patel, HG Bhatt, G Natesan, AB Jha, ... | | 2025 |
| Synthesis, Antimicrobial Evaluation, Molecular Docking and Dynamics Simulations of Novel 2,3‐Disubstituted Quinazolin‐4(3H)‐one Derivatives P Verma, LZ Xiang, U Chaube, G Natesan ChemistrySelect 9 (36), e202403009, 2024 | | 2024 |
| Design, Synthesis, and In-Vitro Biological Evaluation of Novel THQ Derivatives as Anticancer Agents. R Dey, S Shaw, B Patel, H Bhatt, S Patel, N Dixit, U Chaube Malaysian Journal of Medicine & Health Sciences 20, 2024 | | 2024 |
Dr. Hardik BhattInstitute of Pharmacy, Nirma UniversityVerified email at nirmauni.ac.in